ACOG Technology Assessment in Obstetrics and Gynecology. Number 1, July 2002. Genetics and molecular diagnostic testing
- 卷第100卷
- 期第1期
- 印刷ISSN0029-7844
- 文件大小7682.65KB
- 发表时间2002
- DOI10.1016/s0029-7844(02)02157-9
Valdecoxib, a Cyclooxygenase-2-Specific Inhibitor, Is Effective in Treating Primary DysmenorrheaDaniels, Stephen E.; Talwalker, Sheela; Torri, Sarah; Snabes, Michael C.; Recker, David P.; Verburg, Kenneth M. · Obstetrics & Gynecology · 2002
A Single Preoperative Oral Dose of Valdecoxib, a New Cyclooxygenase-2 Specific Inhibitor, Relieves Post-Oral Surgery or Bunionectomy PainWiklund, Richard A. · Survey of Anesthesiology · 2003
A Single Preoperative Oral Dose of Valdecoxib, a New Cyclooxygenase-2 Specific Inhibitor, Relieves Post-Oral Surgery or Bunionectomy PainDesjardins, Paul J.; Shu, Vincent S.; Recker, David P.; Verburg, Kenneth M.; Woolf, Clifford J. · Anesthesiology · 2002
Meta-analysis: upper gastrointestinal tolerability of valdecoxib, a cyclooxygenase-2-specific inhibitor, compared with nonspecific nonsteroidal anti-inflammatory drugs among patients with osteoarthritis and rheumatoid arthritisG. M. Eisen; J. L. Goldstein; D. B. Hanna; D. A. Rublee · 2005